Aberdeen Group’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$40.8M Buy
522,175
+47,872
+10% +$3.74M 0.07% 240
2025
Q1
$34.1M Sell
474,303
-614,049
-56% -$44.2M 0.07% 255
2024
Q4
$80.5M Sell
1,088,352
-223,492
-17% -$16.5M 0.15% 146
2024
Q3
$85.8M Buy
1,311,844
+22,271
+2% +$1.46M 0.16% 150
2024
Q2
$119M Buy
1,289,573
+32,513
+3% +$3M 0.23% 98
2024
Q1
$120M Sell
1,257,060
-48,794
-4% -$4.66M 0.24% 101
2023
Q4
$99.6M Buy
1,305,854
+738,648
+130% +$56.3M 0.22% 110
2023
Q3
$39.3M Buy
567,206
+24,525
+5% +$1.7M 0.1% 193
2023
Q2
$51.2M Buy
542,681
+45,147
+9% +$4.26M 0.12% 166
2023
Q1
$41.2M Buy
497,534
+41,010
+9% +$3.39M 0.1% 202
2022
Q4
$34.1M Buy
456,524
+32,341
+8% +$2.41M 0.09% 240
2022
Q3
$35.1M Buy
424,183
+170,556
+67% +$14.1M 0.1% 219
2022
Q2
$24.2M Buy
253,627
+22,731
+10% +$2.17M 0.08% 255
2022
Q1
$27.7M Sell
230,896
-7,720
-3% -$928K 0.07% 259
2021
Q4
$30.9M Sell
238,616
-12,715
-5% -$1.65M 0.07% 268
2021
Q3
$28.7M Buy
251,331
+21,359
+9% +$2.44M 0.06% 282
2021
Q2
$23.8M Sell
229,972
-4,263
-2% -$442K 0.05% 321
2021
Q1
$19.6M Buy
234,235
+9,644
+4% +$807K 0.04% 348
2020
Q4
$20.5M Buy
224,591
+6,479
+3% +$591K 0.05% 317
2020
Q3
$17.4M Sell
218,112
-32,974
-13% -$2.63M 0.05% 319
2020
Q2
$17.4M Sell
251,086
-8,735
-3% -$604K 0.05% 320
2020
Q1
$16.4M Buy
259,821
+4,995
+2% +$314K 0.05% 305
2019
Q4
$19.8M Buy
254,826
+10,713
+4% +$833K 0.05% 332
2019
Q3
$17.9M Sell
244,113
-2,322
-0.9% -$170K 0.04% 345
2019
Q2
$15.2M Sell
246,435
-7,356
-3% -$454K 0.03% 417
2019
Q1
$16.2M Buy
253,791
+89,625
+55% +$5.72M 0.04% 400
2018
Q4
$8.21M Sell
164,166
-80,211
-33% -$4.01M 0.02% 479
2018
Q3
$14.2M Buy
244,377
+19,587
+9% +$1.14M 0.03% 441
2018
Q2
$10.9M Buy
224,790
+35,685
+19% +$1.73M 0.02% 463
2018
Q1
$8.8M Sell
189,105
-2,061
-1% -$95.9K 0.02% 466
2017
Q4
$7.18M Buy
191,166
+3,150
+2% +$118K 0.01% 507
2017
Q3
$6.85M Buy
+188,016
New +$6.85M 0.01% 514